Aditxt (ADTX) Capital Expenditures (2020 - 2026)

Aditxt (ADTX) recorded quarterly Capital Expenditures of $10379.0 in Q1 2026, up 10.93% quarter-over-quarter from $9356.0 in Q3 2023.

Aditxt (ADTX) Capital Expenditures (2020 - 2026) Analysis & Trends

Aditxt's Capital Expenditures history runs 5 years deep, the most recent figure standing at $10379.0 for Q1 2026.

  • In Q1 2026, Capital Expenditures changed N/A year-over-year to $10379.0; the TTM figure through Mar 2026 stood at $19737.0 (changed N/A YoY), while the FY2025 annual figure was $13743.0, changed N/A from the prior year.
  • Capital Expenditures was $10379.0 for Q1 2026 at Aditxt, up from $9356.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $147802.0 in Q1 2022 to a low of $2.0 in Q2 2023.
  • Historically, Capital Expenditures has averaged $48983.1 across 3 years, with a median of $9867.5 in 2023.
  • The sharpest annual moves came in 2022 and 2023: Capital Expenditures jumped 297.63% in 2022, then tumbled 100.0% in 2023.
  • A 3-year view of Capital Expenditures shows it stood at $88823.0 in 2022, then slumped by 89.47% to $9356.0 in 2023, then advanced by 10.93% to $10379.0 in 2026.
  • The last three Capital Expenditures figures came in at $10379.0 (Q1 2026), $9356.0 (Q3 2023), and $2.0 (Q2 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 133.40 Mn
9 Abivax 91.96 Bn 91.96 Bn - -63,220.27
10 Aditxt 2,485.68 -2.16 Mn 2,868.00 10,379.00

Historic Data

Download Data
DateValue
Mar 31, 2026 10,379.00
Mar 31, 2026 10,379.00
Sep 30, 2023 9,356.00
Sep 30, 2023 9,356.00
Jun 30, 2023 2.00
Jun 30, 2023 2.00
Mar 31, 2023 5,049.00
Mar 31, 2023 5,049.00
Dec 31, 2022 88,823.00
Dec 31, 2022 88,823.00
Sep 30, 2022 4,183.00
Sep 30, 2022 4,183.00
Jun 30, 2022 126,271.00
Jun 30, 2022 126,271.00
Mar 31, 2022 147,802.00
Mar 31, 2022 147,802.00
Dec 31, 2021 115,059.00
Dec 31, 2021 115,059.00
Sep 30, 2021 182,268.00
Sep 30, 2021 182,268.00